Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

FSD Pharma agrees to sell its Cobourg cannabis facility and property for C$16.5M

The company said a deposit of C$660,000 was received on February 24, 2022, and the transaction is expected to close on May 31, 2022

FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc said it has entered into a “firm” agreement to sell its former cannabis processing facility located in Cobourg, Ontario, as well as the 64.4 acre property on which the facility is located.

The company said the purchaser has agreed to pay C$16.5 million in cash for the facility and property, which includes a deposit of C$660,000.

FSD noted the deposit was received on February 24, 2022, and the transaction is expected to close on May 31, 2022.

READ: FSD Pharma says board authorizes repurchase by the company of up to 2 million of its subordinate Class B voting shares

It added that the sale remains subject to the satisfaction of a number of conditions and, if closed, the injection of money will be non-dilutive to shareholders.

FSD Pharma (CSE:HUGE, NASDAQ:HUGE) is a life sciences holding company with two wholly-owned subsidiaries dedicated to building a portfolio of diversified therapeutic assets and innovative healthcare and biotech services.

Contact Sean at sean@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK